Alaunos Therapeutics Inc (TCRT) NPV

Sell:$1.70Buy:$1.90$0.07 (3.93%)

Prices delayed by at least 15 minutes
Sell:$1.70
Buy:$1.90
Change:$0.07 (3.93%)
Deal now
Prices delayed by at least 15 minutes
Sell:$1.70
Buy:$1.90
Change:$0.07 (3.93%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.

Key people

Dale Curtis Hogue
Interim Chief Executive Officer, Director
Ferdinand Groenewald
Vice President - Finance
Holger Weis
Independent Chairman of the Board
Robert J. Hofmeister
Independent Director
Robert W. Postma
Independent Director
Jaime W. Vieser
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US98973P3091
  • Market cap
    $2.88m
  • Employees
    1
  • Shares in issue
    1.60m
  • Exchange
    NASDAQ
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.